期刊
GASTROENTEROLOGY
卷 140, 期 5, 页码 1629-U389出版社
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1053/j.gastro.2011.02.008
关键词
Liver Cancer; Tumor Progression; Metastasis; Tumor Invasion
资金
- National Key Sci-Tech Special Project of China [2008ZX10002-022]
- National Hi-Tech Research and Development Program of China [2007AA02Z479]
- Ministry of Education of China [13-192]
- National Natural Science Foundation [81071741]
- special program of China Postdoctoral Science Foundation [201003236]
BACKGROUND & AIMS: Overexpression of CD151 is associated with poor prognosis for hepatocellular carcinoma (HCC), yet its role in pathogenesis is not known. METHODS: We analyzed the expression of the integrin subunit alpha 6 by quantitative, real-time polymerase chain reaction and immunoblot analyses of 120 HCC tissue samples; its clinical significance was investigated using tissue microarray (TMAs) analysis of samples from 335 patients with HCC. Immunoprecipitation was used to assess the relationship between alpha 6 and CD151. The molecular effects of high expression levels of alpha 6 and CD151 in HCC cells were determined using RNA interference and pharmacologic approaches. RESULTS: Overexpression of alpha 6 correlated with poor prognosis of patients with HCC; alpha 6 formed a complex with endogenous CD151 in HCC cells. In cells that expressed high levels of alpha 6 and CD151, laminin-5 promoted cell spreading by inducing the epithelial-mesenchymal transition (EMT); this effect was not observed in cells that expressed high levels of only alpha 6 or CD151. Cells that expressed high levels of alpha 6 and CD151 underwent the EMT in response to laminin-5, through hyperactivation of phosphatidylinositol- 3-kinase (PI3K), primarily induced via the PI3Kprotein kinase B (Akt)-Snail-phosphatase and tensin homolog feedback pathway. The EMT was reversed by PI3K inhibitors and antibodies against CD151 or alpha 6 in vitro, and was delayed by specific interference with CD151 and alpha 6 in vivo. CONCLUSIONS: High expression levels of CD151 and alpha 6 promote invasiveness of HCC cells. Either of these proteins, or PI3K signaling, might be targets for therapeutics for subgroups of patients with HCC.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据